The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
|Articles|November 8, 2004
A primer on physical safeguards
Complying with the physical safeguards under the Health Insurance Portability & Accountability Act may be the easiest to achieve, since you may already fulfill several of the requirements through adherence to state and federal pharmacy and drug laws.
Advertisement
Advertisement
Related to this article
Mark Garofoli, PharmD, BCGP, CPE, CTTS, explains how to guide patients past crowded combination products, uncertain decongestants, and hidden risks in OTC aisles.
Chad Worz, PharmD, BCGP, FASCP, explains why the Main Street Pharmacy Access Act's reimbursement provisions are key to unlocking pharmacy's clinical future.
Cohort studies found no clear cardiovascular benefit from PPV23 vaccination, leaving its role in cardiovascular prevention unresolved.
A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations.
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
A guide built from conversations with pharmacists on social media and independent pharmacy owners.
Exploring the effects of weight-loss and GLP-1 therapies, researchers determine the specific metabolic determinants that lead to patients’ weight reduction.
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
2
FDA Approves Update for Winrevair Based on Phase 3 HYPERION Trial Data
3
PPV23 Vaccination Found to Not Reduce Cardiovascular Risk
4
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
5